Current Progress in CAR-T Cell Therapy for Hematological Malignancies

Immunotherapies, such as monoclonal antibody therapy and checkpoint inhibitor therapy, have shown inspiring clinical effects for the treatment of cancer. Chimeric antigen receptor T (CAR-T) cells therapy was an efficacious therapeutic approach treating hematological malignancies and encouraging resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Donglei, Xu, Zenghui, Zhuang, Yuan, Ye, Zhenlong, Qian, Qijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738987/
https://www.ncbi.nlm.nih.gov/pubmed/33391429
http://dx.doi.org/10.7150/jca.48976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738987/
https://www.ncbi.nlm.nih.gov/pubmed/33391429
http://dx.doi.org/10.7150/jca.48976

Ejemplares similares